Pharmacokinetics of [3H]-ivermectin in the dog following oral administration of a beef-based chewable formulation containing ivermectin alone or in combination with pyrantel pamoate.
Clark
J N
JN
Merck, Sharp and Dohme Research Laboratories, Rahway, New Jersey 07065-9014.
Daurio
C P
CP
Skelly
B J
BJ
Cheung
E N
EN
Jeffcoat
A R
AR
D000042:Absorption; D000284:Administration, Oral; D000704:Analysis of Variance; D000818:Animals; D001682:Biological Availability; D004184:Dirofilariasis / Q000517:prevention & control*; D004283:Dog Diseases / Q000517:prevention & control*; D004285:Dogs / Q000378:metabolism*; D004338:Drug Combinations; D005260:Female; D007559:Ivermectin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011716:Pyrantel Pamoate / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011897:Random Allocation; D013810:Therapeutic Equivalency
D004338:Drug Combinations; D007559:Ivermectin; D011716:Pyrantel Pamoate